Neuren Pharmaceuticals | NEU - Sales Revenues


Neuren Pharmaceuticals reported AUD42.24M in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Akebia Therapeutics USD 57.62M 1.14M Dec/2025
Alaunos Therapeutics USD 2K 2K Mar/2025
Avita Medical AUD 17.61M 805K Dec/2025
Clinuvel Pharmaceuticals AUD 36.93M 22.44M Dec/2025
Dianthus Therapeutics USD 463K 179K Mar/2026
Genetic Signatures AUD 11.19M 5.56M Dec/2025
Ionis Pharmaceuticals USD 268M 22M Jun/2026
Medical Developments International AUD 21.57M 12.04M Dec/2025
Neuren Pharmaceuticals AUD 42.24M 28.1M Dec/2025
Organon & Co USD 1.56B 100M Jun/2026
Paradigm Biopharmaceuticals AUD 284.06K 292.06K Dec/2025
PYC Therapeutics AUD 11.04M 2.44M Dec/2025
Starpharma Holdings AUD 10.83M 9.12M Dec/2025
Tectonic Therapeutic USD 0 0 Dec/2024
Telix Pharmaceuticals AUD 477.35M 63.92M Jun/2026
Viatris USD 3.76B 240M Jun/2026
Xeris Pharmaceuticals USD 83.13M 2.68M Mar/2026